The Trustee for BLOODWORKS UNIT TRUST

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Employees: -

Market Cap: -

Website: https://www.telethon7.com/

Clinical Trials

Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets

Phase 1

Conditions: Reversal of Platelet Aggregation Inhibitors

Interventions: Biological: Autologous Room Temperature stored Platelet transfusion
Biological: Autologous Cold Stored Platelet transfusion

First Posted Date: 2021-11-08

Last Posted Date: 2021-11-08

Lead Sponsor: Bloodworks

Target Recruit Count: 10

Registration Number: NCT05111028

Locations: 🇺🇸
Bloodworks Northwest Research Institute, Seattle, Washington, United States

Von Willebrand Factor in Pregnancy (VIP) Study

Conditions: Von Willebrand Diseases

Interventions: Other: Use of a postpartum diary and additional blood draws
Drug: Tranexamic acid
Drug: VWF replacement therapy with Wilate
Other: Use of a postpartum diary and additional blood draws.

First Posted Date: 2019-10-31

Last Posted Date: 2021-01-28

Lead Sponsor: Bloodworks

Target Recruit Count: 110

Registration Number: NCT04146376

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
University of Miami, Miami, Florida, United States

and more 8 locations

Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets

Phase 1

Conditions: Platelet Dysfunction Due to Drugs
Bleeding
Platelet Dysfunction

Interventions: Drug: Autologous Platelet Transfusion (room-temperature-stored)
Drug: Autologous Platelet Transfusion (cold-stored 5 days)
Drug: Autologous Platelet Transfusion (cold-stored 10 days)
Drug: Autologous Platelet Transfusion (cold-stored 15 days)
Drug: Aspirin
Drug: Clopidogrel

First Posted Date: 2018-12-27

Last Posted Date: 2020-07-14

Lead Sponsor: Bloodworks

Target Recruit Count: 60

Registration Number: NCT03787927

Locations: 🇺🇸
Bloodworks Northwest Research Institute, Seattle, Washington, United States

Joint Health Study

Completed

Conditions: Hemophilia B

First Posted Date: 2017-12-02

Last Posted Date: 2022-06-22

Lead Sponsor: Bloodworks

Target Recruit Count: 8

Registration Number: NCT03358836

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States
🇺🇸
Orthopaedic Institute for Children at University of California Los Angeles, Los Angeles, California, United States
🇺🇸
Tulane University, New Orleans, Louisiana, United States

and more 2 locations

Comparison of Ideal vs. Actual Weight Base Factor Dosing

Not Applicable

Conditions: Hemophilia A

Interventions: Other: Ideal Body Weight First
Other: Actual Body Weight First

First Posted Date: 2017-09-18

Last Posted Date: 2017-09-18

Lead Sponsor: Bloodworks

Target Recruit Count: 20

Registration Number: NCT03286153

Locations: 🇺🇸
Washington Center for Bleeding Disorders at Bloodworks Northwest, Seattle, Washington, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

and more 1 locations

Cold Apheresis Platelets in PAS

Phase 1

Conditions: Platelet Transfusion

Interventions: Procedure: Apheresis platelet collection
Other: Refrigerated storage of apheresis platelets in PAS/plasma
Radiation: Infusion of aliquot of autologous radiolabeled platelets
Other: In vitro tests

First Posted Date: 2016-04-28

Last Posted Date: 2018-05-14

Lead Sponsor: Bloodworks

Target Recruit Count: 80

Registration Number: NCT02754414

Locations: 🇺🇸
Bloodworks Northwest (formerly Puget Sound Blood Center), Seattle, Washington, United States

Assessment of Whole Blood Cold Stored Platelets

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: Blood Collection and autologous re-infusion

First Posted Date: 2013-12-10

Last Posted Date: 2017-08-04

Lead Sponsor: Bloodworks

Target Recruit Count: 31

Registration Number: NCT02006368

Locations: 🇺🇸
Puget Sound Blood Center, Seattle, Washington, United States

A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura

Early Phase 1

Completed

Conditions: Purpura, Thrombotic Thrombocytopenic
TTP

Interventions: Drug: N-Acetylcysteine

First Posted Date: 2013-03-11

Last Posted Date: 2017-09-20

Lead Sponsor: Bloodworks

Target Recruit Count: 3

Registration Number: NCT01808521

Locations: 🇺🇸
Puget Sound Blood Center, Seattle, Washington, United States

A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

Phase 1

Completed

Conditions: Sickle Cell Disease
Sickle Cell Anemia

Interventions: Drug: N-Acetylcysteine

First Posted Date: 2013-02-27

Last Posted Date: 2020-07-09

Lead Sponsor: Bloodworks

Target Recruit Count: 21

Registration Number: NCT01800526

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Retaining Donors and Increasing Donation Frequency

Completed

Conditions: Blood Donors

First Posted Date: 2000-05-26

Last Posted Date: 2016-04-11

Lead Sponsor: Bloodworks

Registration Number: NCT00005721

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy